FDA Approves Biogen's MS Drug Plegridy

Home › FDA Approves Biogen's MS Drug Plegridy

Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.

21.05	Tennesse Program to Provide Free Diapers to Families
21.05	Atlantic Tropical Weather Outlook
21.05	Eastern North Pacific Tropical Weather Outlook
21.05	Online car retailer Cazoo enters administration
21.05	Sherwin-Williams Launches Pipeclad Frac-Shun ERC Technology
21.05	Kosas Launches Blush Is Life Collection
21.05	Avery Dennison receives APR critical guidance for HDPE plastic
21.05	RAAA announces two staff promotions
More »

je.st